CAMX.ST
Price:
$599
Market Cap:
$35.23B
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat opioid use disorder Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CA...[Read more]
Industry
Biotechnology
IPO Date
2015-12-03
Stock Exchange
STO
Ticker
CAMX.ST
According to Camurus AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 156.40. This represents a change of -368.35% compared to the average of -58.28 of the last 4 quarters.
The mean historical PE Ratio of Camurus AB (publ) over the last ten years is 10.41. The current 156.40 PE Ratio has changed 150.15% with respect to the historical average. Over the past ten years (40 quarters), CAMX.ST's PE Ratio was at its highest in in the June 2022 quarter at 323.80. The PE Ratio was at its lowest in in the March 2022 quarter at -3062.23.
Average
10.41
Median
-12.92
Minimum
-90.79
Maximum
250.39
Discovering the peaks and valleys of Camurus AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 335.39%
Maximum Annual PE Ratio = 250.39
Minimum Annual Increase = -375.80%
Minimum Annual PE Ratio = -90.79
Year | PE Ratio | Change |
---|---|---|
2023 | 69.18 | -72.37% |
2022 | 250.39 | -375.80% |
2021 | -90.79 | 54.65% |
2020 | -58.70 | 333.11% |
2019 | -13.55 | 30.62% |
2018 | -10.38 | -62.11% |
2017 | -27.39 | -48.82% |
2016 | -53.51 | 335.39% |
2015 | -12.29 | -124.04% |
2014 | 51.13 | 105.26% |
The current PE Ratio of Camurus AB (publ) (CAMX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
76.26
5-year avg
31.30
10-year avg
10.41
Camurus AB (publ)’s PE Ratio is greater than BioArctic AB (publ) (-146.68), greater than Calliditas Therapeutics AB (publ) (-23.25), greater than Oncopeptides AB (publ) (-1.67), greater than Hansa Biopharma AB (publ) (-3.35), greater than Swedish Orphan Biovitrum AB (publ) (31.74),
Company | PE Ratio | Market cap |
---|---|---|
-146.68 | $12.56B | |
-23.25 | $11.24B | |
-1.67 | $438.37M | |
-3.35 | $2.19B | |
31.74 | $111.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Camurus AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Camurus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Camurus AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Camurus AB (publ) (CAMX.ST)?
What is the highest PE Ratio for Camurus AB (publ) (CAMX.ST)?
What is the 3-year average PE Ratio for Camurus AB (publ) (CAMX.ST)?
What is the 5-year average PE Ratio for Camurus AB (publ) (CAMX.ST)?
How does the current PE Ratio for Camurus AB (publ) (CAMX.ST) compare to its historical average?